NCT00785668View on ClinicalTrials.gov

A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

November 30, 2007

Study Completion Date

February 29, 2008

Conditions

Asthma

Interventions

DRUG

AER 001

10 mg dry powder administered using a handheld device

Trial Locations (1)

SE1 1YR

Guy's Drug Research Unit a division of Quintiles Ltd., London

Sponsors

Lead Sponsor

Aerovance, Inc.

All Listed Sponsors

lead

Aerovance, Inc.

INDUSTRY

NCT00785668 - A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects | Biotech Hunter | Biotech Hunter